Gepato-gastroenterologik tadqiqotlar jurnali 2026 №1

Maqola mavzusi

НАРУШЕНИЯ МИНЕРАЛЬНОГО ОБМЕНА НА ФОНЕ ВОСПАЛИТЕЛЬНЫХ ЗАБОЛЕВАНИЙ КИШЕЧНИКА (101-104)

Mualliflar

Бекжанова О.Е. Олимжанов К.Ж.

Muassasa

Ташкентский государственный стоматологический институт

Annotatsiya

В литературе нет неоднозначного ответа в отношении динамики маркеров метаболизма костной ткани при ВЗК, неясна и направленность динамики остеокальцина. Доказано, что одним из клинических осложнений ВЗК являются нарушения минерального обмена, приводящие к остеопении и остеопорозу. Поэтому пациентам с ВЗК покащзано регулярное исследование на наличие патологии минерального обмена, Биохимические маркеры костного метаболизма, отражают баланс между резорбцией и ремоделированием кости. Патогенез снижения минеральной плотности костей при ВЗК многофакторен. Уровни Са и витамина D способны не только вызывать остеопороз, но и инициировать вторичной гиперпаратиреоз. У пациентов ВЗК из-за низкой концентрации витамина D уровень ПТГ повышен, при этом у большинства пациентов концентрации кальция и фосфатов находились в пределах нормы.

Kalit so'zlar

Ключевые слова: минеральный обмен, воспалительные заболквания кишечника, костный метаболизм, остеопороз, виатмин D.

Adabiyotlar

СПИСОК ЛИТЕРАТУРЫ Abreu M.T., Kantorovich V., Vasiliauskas E.A., Gruntmanis U., Matuk R., Daigle K., Chen S., Zehnder D., Lin Y.C., Yang H., et al. Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn’s disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density. Gut. 2004;53:1129–1136. doi: 10.1136/gut.2003.036657. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 1. Biernacka K.B., Barańska D., Grzelak P., Czkwianianc E., Szabelska-Zakrzewska K. Up-to-date overview of imaging techniques in the diagnosis and management of inflammatory bowel diseases. Prz. Gastroenterol. 2019;14:19–25. doi: 10.5114/pg.2019.83423. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 2. Bravenboer N., Oostlander A.E., van Bodegraven A.A. Bone loss in patients with inflammatory bowel disease: Cause, detection and treatment. Curr. Opin. Gastroenterol. 2021;37:128–134. doi: 10.1097/MOG.0000000000000710. [PubMed] [CrossRef] [Google Scholar] 3. Bregenzer N., Erban P., Albrich H., Schmitz G., Feuerbach S., Schölmerich J., Andus T. Screening for osteoporosis in patients with inflammatory bowel disease by using urinary N-telopeptides. Eur. J. Gastroenterol. Hepatol. 2002;14:599–605. doi: 10.1097/00042737-200206000-00004. [PubMed] [CrossRef] 4. Chetcuti Zammit S., Ellul P., Girardin G., Valpiani D., Nielsen K.R., Olsen J., Goldis A., Lazar D., Shonová O., Nováková M., et al. Vitamin D deficiency in a European inflammatory bowel disease inception cohort: An Epi-IBD study. Eur. J. Gastroenterol. Hepatol. 2018;30:1297–1303. doi: 10.1097/MEG.0000000000001238. [PubMed] [CrossRef] [Google Scholar] 5. Domislović V., Vranešić Bender D., Barišić A., Brinar M., Ljubas Kelečić D., Rotim C., Novosel M., Matašin M., Krznarić Ž. High prevalence of untreated and undertreated vitamin d deficiency and insufficiency in patients with inflammatory bowel disease. Acta Clin. Croat. 2020;59:109–118. [PMC free article] [PubMed] [Google Scholar] 6. Duggan P., O’Brien M., Kiely M., McCarthy J., Shanahan F., Cashman K.D. Vitamin K status in patients with Crohn’s disease and relationship to bone turnover. Am. J. Gastroenterol. 2004;99:2178–2185. doi: 10.1111/j.1572-0241.2004.40071.x. [PubMed] [CrossRef] [Google Scholar] 7. Dumitrescu G., Mihai C., Dranga M., Prelipcean C.C. Serum 25-hydroxyvitamin D concentration and inflammatory bowel disease characteristics in Romania. World J. Gastroenterol. 2014;20:2392–2396. doi: 10.3748/wjg.v20.i9.2392. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 8. Frigstad S.O., Høivik M., Jahnsen J., Dahl S.R., Cvancarova M., Grimstad T., Berset I.P., Huppertz-Hauss G., Hovde Ø., Torp R., et al. Vitamin D deficiency in inflammatory bowel disease: Prevalence and predictors in a Norwegian outpatient population. Scand. J. Gastroenterol. 2017;52:100–106. doi: 10.1080/00365521.2016.1233577. [PubMed] [CrossRef] [Google Scholar] 9. Gilman J., Shanahan F., Cashman K.D. Altered levels of biochemical indices of bone turnover and bone-related vitamins in patients with Crohn’s disease and ulcerative colitis. Aliment. Pharmacol. Ther. 2006;23:1007–1016. doi: 10.1111/j.1365-2036.2006.02835.x. [PubMed] [CrossRef] [Google Scholar] 10. Gionchetti P., Dignass A., Danese S., Magro Dias F.J., Rogler G., Lakatos P.L., Adamina M., Ardizzone S., Buskens C.J., Sebastian S., et al. Third European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 2: Surgical Management and Special Situations. J. Crohns. Colitis. 2017;11:135–149. doi: 10.1093/ecco-jcc/jjw169. [PubMed] [CrossRef] [Google Scholar] 11. Gubatan J., Moss A.C. Vitamin D in inflammatory bowel disease: More than just a supplement. Curr. Opin. Gastroenterol. 2018;34:217–225. doi: 10.1097/MOG.0000000000000449. [PubMed] [CrossRef] [Google Scholar] 12. Holick M.F., Binkley N.C., Bischoff-Ferrari H.A., Gordon C.M., Hanley D.A., Heaney R.P., Murad M.H., Weaver C.M., Endocrine Society Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 2011;96:1911–1930. doi: 10.1210/jc.2011-0385. [PubMed] [CrossRef] [Google Scholar] 13. Jahnsen J., Falch J.A., Mowinckel P., Aadland E. Bone mineral density in patients with inflammatory bowel disease: A population-based prospective two-year follow-up study. Scand J. Gastroenterol. 2004;39:145–153. doi: 10.1080/00365520310007873. [PubMed] [CrossRef] [Google Scholar] 14. Johansson H., Odén A., Kanis J.A., McCloskey E.V., Morris H.A., Cooper C., Vasikaran S., IFCC-IOF Joint Working Group on Standardisation of Biochemical Markers of Bone Turnover A meta-analysis of reference markers of bone turnover for prediction of fracture. Calcif. Tissue Int. 2014;94:560–567. doi: 10.1007/s00223-014-9842-y. [PubMed] [CrossRef] [Google Scholar] 15. Kaplan G.G., Bernstein C.N., Coward S., Bitton A., Murthy S.K., Nguyen G.C., Lee K., Cooke-Lauder J., Benchimol E.I. The Impact of Inflammatory Bowel Disease in Canada 2018: Epidemiology. J. Can. Assoc. Gastroenterol. 2019;2((Suppl. S1)):S6–S16. doi: 10.1093/jcag/gwy054. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 16. Lima C.A., Lyra A.C., Rocha R., Santana G.O. Risk factors for osteoporosis in inflammatory bowel disease patients. World J. Gastrointest. Pathophysiol. 2015;6:210–218. 17. Lo B., Holm J.P., Vester-Andersen M.K., Bendtsen F., Vind I., Burisch J. Incidence, Risk Factors and Evaluation of Osteoporosis in Patients with Inflammatory Bowel Disease: A Danish Population-Based Inception Cohort with 10 Years of Follow-Up. J. Crohns. Colitis. 2020;14:904–914. doi: 10.1093/ecco-jcc/jjaa019. [PubMed] [CrossRef] [Google Scholar] 18. Łodyga M., Eder P., Gawron-Kiszka M., Dobrowolska A., Gonciarz M., Hartleb M., Kłopocka M., Małecka-Wojciesko E., Radwan P., Reguła J., et al. Guidelines for the management of patients with Crohn’s disease. Recommendations of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology. Prz. Gastroenterol. 2021;16:257–296. doi: 10.5114/pg.2021.110914. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 19. McCarthy D., Duggan P., O’Brien M., Kiely M., McCarthy J., Shanahan F., Cashman K.D. Seasonality of vitamin D status and bone turnover in patients with Crohn’s disease. Aliment. Pharmacol. Ther. 2005;21:1073–1083. doi: 10.1111/j.1365-2036.2005.02446.x. [PubMed] [CrossRef] [Google Scholar] 20. Molodecky N.A., Soon I.S., Rabi D.M., Ghali W.A., Ferris M., Chernoff G., Benchimol E.I., Panaccione R., Ghosh S., Barkema H.W., et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46–54.e42; quiz e30. doi: 10.1053/j.gastro.2011.10.001. [PubMed] [CrossRef] [Google Scholar] 21. Oh H.J., Ryu K.H., Park B.J., Yoon B.H. Osteoporosis and Osteoporotic Fractures in Gastrointestinal Disease. J. Bone Metab. 2018;25:213–217. doi: 10.11005/jbm.2018.25.4.213. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 22. Płudowski P., Ducki C., Konstantynowicz J., Jaworski M. Vitamin D status in Poland. Pol. Arch. Med. Wewn. 2016;126:530–539. doi: 10.20452/pamw.3479. 23. Prosnitz A.R., Leonard M.B., Shults J., Zemel B.S., Hollis B.W., Denson L.A., Baldassano R.N., Cohen A.B., Thayu M. Changes in vitamin D and parathyroid hormone metabolism in incident pediatric Crohn’s disease. Inflamm. Bowel Dis. 2013;19:45–53. doi: 10.1002/ibd.22969. 24. Rasouli E., Sadeghi N., Parsi A., Hashemi S.J., Nayebi M., Shayesteh A. Relationship Between Vitamin D Deficiency and Disease Activity in Patients with Inflammatory Bowel Disease in Ahvaz, Iran. Clin. Exp. Gastroenterol. 2020;13:419–425. doi: 10.2147/CEG.S254278. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 25. Sánchez-Cano D., Ruiz-Villaverde R., Callejas-Rubio J.L., Pérez C.C., García M.G., Ortego Centeno N. Déficit de vitamina D y densidad mineral ósea en la enfermedad de Crohn [Vitamin D deficiency and bone mineral density in Crohn’s disease] Med. Clin. (Barc) 2011;137:62–65. doi: 10.1016/j.medcli.2010.09.032. [PubMed] [CrossRef] [Google Scholar] 26. Schäffler H., Schmidt M., Huth A., Reiner J., Glass Ä., Lamprecht G. Clinical factors are associated with vitamin D levels in IBD patients: A retrospective analysis. J. Dig. Dis. 2018;19:24–32. doi: 10.1111/1751-2980.12565. [PubMed] [CrossRef] [Google Scholar 27. Schoon E.J., Geerling B.G., Van Dooren I.M., Schurgers L.J., Vermeer C., Brummer R.J., Stockbrügger R.W. Abnormal bone turnover in long-standing Crohn’s disease in remission. Aliment Pharmacol. Ther. 2001;15:783–792. doi: 10.1046/j.1365-2036.2001.00997.x. [PubMed] [CrossRef] [Google Scholar] 28. Silvennoinen J. Relationships between vitamin, D.; parathyroid hormone and bone mineral density in inflammatory bowel disease. J. Intern. Med. 1996;239:131–137. doi: 10.1046/j.1365-2796.1996.420765000.x. [PubMed] [CrossRef] [Google Scholar] 29. Szymańska S., Matuszczyk M., Osuch M., Meglicka M., Szymanska E., Bierła J., Kierkuś J. Inflammatory bowel disease—One entity with many molecular faces. Prz. Gastroenterol. 2019;14:228–232. doi: 10.5114/pg.2019.90249. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 30. Tan B., Li P., Lv H., Li Y., Wang O., Xing X.P., Qian J.M. Vitamin D levels and bone metabolism in Chinese adult patients with inflammatory bowel disease. J. Dig. Dis. 2014;15:116–123. doi: 10.1111/1751-2980.12118. [PubMed] [CrossRef] [Google Scholar] 31. Tulewicz-Marti EM, Lewandowski K, Rydzewska G. Bone Metabolism Alteration in Patients with Inflammatory Bowel Disease. J Clin Med. 2022 Jul 16;11(14):4138. doi: 10.3390/jcm11144138. PMID: 35887903; PMCID: PMC9316624. 32. Vasikaran S., Eastell R., Bruyère O., Foldes A.J., Garnero P., Griesmacher A., McClung M., Morris H.A., Silverman S., Trenti T., et al. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: A need for international reference standards. Osteoporos. Int. 2011;22:391–420. doi: 10.1007/s00198-010-1501-1. [PubMed] [CrossRef] [Google Scholar] 33. Zhang Q., Shi L., Peng N., Xu S., Zhang M., Zhang S., Li H., Zhuang H., Gong M., Wu D., et al. Serum concentrations of 25-hydroxyvitamin D and its association with bone mineral density and serum parathyroid hormone levels during winter in urban males from Guiyang, Southwest China. Br. J. Nutr. 2016;115:960–966. doi: 10.1017/S0007114515005383. [PubMed] [CrossRef] [Google Scholar.